Founded with the mission to advance scientific research and innovation, ABclonal is a biotechnology company specializing in the supply of high-quality antibody and molecular enzyme reagents. The company aims to support global scientific communities by providing reliable and efficient tools for research and diagnostics. ABclonal's product portfolio includes a wide range of qPCR mixes, recombinant proteins, and monoclonal antibodies, catering primarily to researchers in academic institutions, pharmaceutical companies, and clinical laboratories.

ABclonal has garnered attention from notable scientists and investors in the biotechnology sector, contributing to its rapid growth and industry recognition. The company has achieved significant milestones, including the publication of research in prestigious journals like Science, which underscores the reliability and impact of its products. ABclonal's contributions have facilitated advancements in various fields of biological research, thereby solidifying its reputation as a key player in the global biotech supply market.